Indications include
- Age-related Macular Degeneration
- Corneal graft rejection
- Diabetic Macular Edema (DME)
- Leber Hereditary Optic Neuropathy
- Neovascular glaucoma
Recent assignments
- Prepare and submit an EU ODD annual report and review the sponsorship transfer dossier
- Provide CMC Support on a gene therapy product
- Perform a critical analysis of toxicology reports and prepare recommendations
- Prepare and submit as EU Legal Representative a CTA in 5 EU countries (incl. development of IB & IMPD)
- Provide pre-market PV services for a clinical trial in France with a gene therapy product
- Advice on clinical development plan and market access strategy
Products
Projects
Markets